HomeMAIA • NYSEAMERICAN
add
Maia Biotechnology Inc
$1.58
Makalipas ang Oras ng Trabaho:(0.95%)-0.015
$1.57
Sarado: Ago 15, 4:11:22 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
Nakaraang pagsara
$1.56
Sakop ng araw
$1.54 - $1.64
Sakop ng taon
$1.40 - $3.74
Market cap
52.13M USD
Average na Volume
456.86K
P/E ratio
-
Dividend yield
-
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 5.17M | 35.41% |
Net na kita | -5.35M | 39.78% |
Net profit margin | — | — |
Kita sa bawat share | -0.17 | 58.02% |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 10.14M | -12.39% |
Kabuuang asset | 11.05M | -8.10% |
Kabuuang sagutin | 7.17M | -19.06% |
Kabuuang equity | 3.88M | — |
Natitirang share | 32.99M | — |
Presyo para makapag-book | 13.00 | — |
Return on assets | -112.74% | — |
Return on capital | -292.89% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -5.35M | 39.78% |
Cash mula sa mga operasyon | -4.14M | 11.73% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 3.41M | -57.33% |
Net change in cash | -718.77K | -121.73% |
Malayang cash flow | -2.34M | 30.70% |
Tungkol
MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells. Wikipedia
Itinatag
2018
Headquarters
Website
Mga Empleyado
13
